Global Search

Search articles, concepts, and chapters

Baxter Sally

๐Ÿ‡ด๐Ÿ‡ฒ Fleet Science Center
ORCIDOpenAlex3 articles in GJC

3 articles in GJC

1.

Tirzepatide is Associated With Reduced Risk of Primary Open-Angle Glaucoma and Ocular Hypertension in Patients With Type 2 Diabetes.

Hong Alexander T, Lin Forest, Baxter Sally, Weinreb Robert N

Am J OphthalmolMar 20260 citationsCohort Study

Tirzepatide significantly reduced primary open-angle glaucoma, ocular hypertension, and glaucoma treatment risk in type 2 diabetes patients. This suggests a potential neuroprotective or pressure-lowering benefit, offering a novel therapeutic avenue for glaucoma management.

All 3 articles loaded